Reviva Pharmaceuticals Holdings Inc. (RVPH) Live Share Price, Invest From India

Reviva Pharmaceuticals Holdings Inc. Stock Performance

as on June 6, 2026 at 6:56 am IST

Day's Low
Day's High
$0.61
Day's Price Range
$0.72
$0.71
14.08%
Downside
1.41%
Upside
52 Week's Low
52 Week's High
$0.26
52-Week Price Range
$17.98
$0.71
63.10%
Downside
2432.39%
Upside

Reviva Pharmaceuticals Holdings Inc. share price movements today

Previous Close: $0.61
Open: $0.65
Volume: 979.7K
Day's Low - High: $0.61 - $0.72
52 Week Low - High: $0.26 - $17.98

Reviva Pharmaceuticals Holdings Inc. Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Reviva Pharmaceuticals Holdings Inc. Stock Fundamentals & Key Indicators

Check Reviva Pharmaceuticals Holdings Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.8M

EPS (TTM)

-1.6

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-10.1M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-256.20%

Reviva Pharmaceuticals Holdings Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Reviva Pharmaceuticals Holdings Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Reviva Pharmaceuticals Holdings Inc.	BUY	$7.8M	NA	NA	0.00%	NA
Revolution Medicines Inc	BUY	$32.2B	410.63%	NA	0.00%	NA
Alnylam Pharmaceuticals Inc	BUY	$39.1B	108.54%	73.51	12.55%	NA
Vertex Pharmaceuticals Inc	BUY	$108.7B	110.42%	25.45	35.51%	NA
Regeneron Pharmaceuticals Inc	BUY	$64.9B	22.83%	15.11	29.65%	0.59%

Analyst Recommendation on Reviva Pharmaceuticals Holdings Inc. Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Reviva Pharmaceuticals Holdings Inc.. Average target price of $25

Reviva Pharmaceuticals Holdings Inc. Share Price Target

Get share price movements and forecasts by analysts on Reviva Pharmaceuticals Holdings Inc..

What analysts predicted

97.16%UPSIDE

Target Price

$25

Current Price

$0.71

Analyzed by

11 Analysts

Target

$25.00

Reviva Pharmaceuticals Holdings Inc. target price $25, a slight upside of 97.16% compared to current price of $0.71. According to 11 analysts rating.

Indian Investors' Interest in Reviva Pharmaceuticals Holdings Inc. Stock

Search interest for Reviva Pharmaceuticals Holdings Inc. Stock has increased by 2% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 7, 2026 to June 6, 2026

Change:2% versus previous 30 day period

Reviva Pharmaceuticals Holdings Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-9	-7	-8	-8	-6	-6	-6	-4	-3	-3
EBITDA	-	-6	-7	-8	-	-6	-6	-4	-3	-3
Interest Expense	-	0	0	0	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-9	-7	-7	-8	-6	-6	-6	-4	-3	-3
Income Tax Expense	-	0	0	-	-	0	0	0	0	0
Net Income	-9	-7	-7	-8	-6	-6	-6	-4	-3	-3
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Reviva Pharmaceuticals Holdings Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	-	0	-	-	-	-	-
Operating Income	0	-2	-10	-24	-39	-30	-20
EBITDA	0	-2	-8	-24	-39	-29	-19
Interest Expense	0	1	0	0	0	0	0
Depreciation	0	0	0	-	-	-	-
Income Before Tax	0	-3	-8	-24	-39	-29	-19
Income Tax Expense	0	0	0	0	0	0	0
Net Income	0	-3	-8	-24	-39	-29	-19
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Reviva Pharmaceuticals Holdings Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-7	-7	-8	-6	-6	-6	-4	-3	-3
Operating Cash Flow	-11	-8	-4	-9	-8	-5	-5	-5	-3
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	0	2	3	17	0	10	8	7	11
Change in Cash	-11	-5	0	7	-8	5	2	1	7

Reviva Pharmaceuticals Holdings Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	0	-3	-8	-24	-39	-29	-19
Operating Cash Flow	0	-4	-10	-18	-28	-33	-24
Investing Cash Flow	-	-	-	-	-	-	-
Financing Cash Flow	0	12	31	7	33	23	25
Change in Cash	0	8	20	-11	4	-9	0

Global Institutional Holdings in Reviva Pharmaceuticals Holdings Inc.

Funds	Holdings
Armistice Capital, LLC	10.08%
Virtu Financial LLC	0.56%
Jane Street Group LLC	0.76%
NRI Wealth Management LC	0.01%
Cetera Investment Advisers	0.05%

See all

Reviva Pharmaceuticals Holdings Inc. News & Key Events

Insights on Reviva Pharmaceuticals Holdings Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, REVOLUTION Medicines Inc has given 473.9% return, outperforming this stock by 573.7%
NO EFFECT
Against Peers
In the last 1 year, REVOLUTION Medicines Inc has given 268.4% return, outperforming this stock by 366.4%
NEGATIVE IMPACT
Price Dip
In the last 7 days, RVPH stock has moved down by -58.2%

About Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, such as schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis. It also engages in the clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis. In addition, the company is in preclinical development for the treatment of psoriasis; and RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.

Organisation	Reviva Pharmaceuticals Holdings Inc.
Headquarters	10080 N. Wolfe Road, Cupertino, CA, United States, 95014
Industry	Biotechnology
CEO	Dr. Laxminarayan Bhat Ph.D.
E-voting on shares	Click here to vote

Key Management of Reviva Pharmaceuticals Holdings Inc.

Name	Title
Dr. Laxminarayan Bhat Ph.D.	Founder, CEO, President & Director
Mr. Narayan Prabhu	CFO, Treasurer & Secretary

FAQs

What is Reviva Pharmaceuticals Holdings Inc. share price today?

Reviva Pharmaceuticals Holdings Inc. share price today is $0.71 as on June 6, 2026 at 1:26 am IST at the close of the market. Reviva Pharmaceuticals Holdings Inc. share today touched a day high of $0.72 and a low of $0.61.

What is the 52 week high and 52 week low for Reviva Pharmaceuticals Holdings Inc. share?

Reviva Pharmaceuticals Holdings Inc. share touched a 52 week high of $17.98 on June 9, 2025 and a 52 week low of $0.26 on May 13, 2026. Reviva Pharmaceuticals Holdings Inc. stock price today i.e. June 6, 2026 at 1:26 am IST is closed at $0.71,which is 96.05% down from its 52 week high and 170.99% up from its 52 week low.

What is Reviva Pharmaceuticals Holdings Inc.'s market capitalisation today?

Reviva Pharmaceuticals Holdings Inc. market capitalisation is $0.00T as on June 6, 2026 at 1:26 am IST.

How to invest in Reviva Pharmaceuticals Holdings Inc. Stock (RVPH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Reviva Pharmaceuticals Holdings Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Reviva Pharmaceuticals Holdings Inc. Shares that will get you 2.1127 shares as per Reviva Pharmaceuticals Holdings Inc. share price of $0.71 per share as on June 6, 2026 at 1:26 am IST.

What is the minimum amount required to buy Reviva Pharmaceuticals Holdings Inc. Stock (RVPH) from India?

Indian investors can start investing in Reviva Pharmaceuticals Holdings Inc. (RVPH) shares with as little as ₹94.935 or $1 (as of June 6, 2026 at 3:52 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.35 in Reviva Pharmaceuticals Holdings Inc. stock (as per the Rupee-Dollar exchange rate as on June 6, 2026 at 3:52 pm IST). Based on Reviva Pharmaceuticals Holdings Inc. share’s latest price of $0.71 as on June 6, 2026 at 1:26 am IST, you will get 14.0845 shares of Reviva Pharmaceuticals Holdings Inc.. Learn more about fractional shares .